Gemcitabine in elderly patients with advanced pancreatic cancer

AIM: To assess feasibility, tolerability and efficacy of gemcitabine-based chemotherapy in patients ≥ 75 years old with advanced pancreatic cancer. METHODS: All consecutive patients ≥ 75 years old with advanced pancreatic adenocarcinoma were included in this retrospective study. Necessary criteria t...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Hentic, Olivia, Dreyer, Chantal, Rebours, Vinciane, Zappa, Magaly, Lévy, Philippe, Raymond, Eric, Ruszniewski, Philippe, Hammel, Pascal
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Baishideng Publishing Group Co., Limited 2011
Pynciau:
Brief Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3163247/
https://ncbi.nlm.nih.gov/pubmed/21941416
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v17.i30.3497
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg